On the public citation graph

Fragment-based drug discovery campaigns guided by native mass spectrometry

0 signed · 153 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-uopenalex-snapshot
The Design of Leadlike Combinatorial Libraries
inferredcites →https://doi.org/10.1002/1878-0261.13277openalex-snapshot
Fragment‐based drug discovery—the importance of high‐quality molecule libraries
inferredcites →https://doi.org/10.1002/anie.201702888openalex-snapshot
Fragment Screening against the EthR–DNA Interaction by Native Mass Spectrometry
inferredcites →https://doi.org/10.1002/anie.202010316openalex-snapshot
Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays**
inferredcites →https://doi.org/10.1002/anie.202104947openalex-snapshot
Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates
inferredcites →https://doi.org/10.1002/cbic.202200322openalex-snapshot
Native Mass Spectrometry‐Guided Screening Identifies Hit Fragments for HOP‐HSP90 PPI Inhibition**
inferredcites →https://doi.org/10.1002/chem.201801556openalex-snapshot
Structural Mass Spectrometry of Membrane Proteins within Their Native Lipid Environments
inferredcites →https://doi.org/10.1002/cmdc.201500267openalex-snapshot
One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists
inferredcites →https://doi.org/10.1002/cmdc.201700177openalex-snapshot
Critical Evaluation of Native Electrospray Ionization Mass Spectrometry for Fragment‐Based Screening
inferredcites →https://doi.org/10.1002/cmdc.202100324openalex-snapshot
Fragment‐Based Drug Discovery for RNA Targets
inferredcites →https://doi.org/10.1002/cncr.35238openalex-snapshot
FDA approves capivasertib with fulvestrant for breast cancer
inferredcites →https://doi.org/10.1002/jms.1355openalex-snapshot
Binding constant determination of high‐affinity protein–ligand complexes by electrospray ionization mass spectrometry and ligand competition
inferredcites →https://doi.org/10.1002/jms.4578openalex-snapshot
Native mass spectrometry—A valuable tool in structural biology
inferredcites →https://doi.org/10.1002/rcm.6925openalex-snapshot
Application of the Exactive Plus EMR for automated protein–ligand screening by non‐covalent mass spectrometry
inferredcites →https://doi.org/10.1002/rcm.8570openalex-snapshot
Native ion mobility mass spectrometry reveals that small organic acid fragments impart gas‐phase stability to carbonic anhydrase II
inferredcites →https://doi.org/10.1007/978-1-0716-2325-1_12openalex-snapshot
Deconvolving Native and Intact Protein Mass Spectra with UniDec
inferredcites →https://doi.org/10.1007/s10858-013-9740-zopenalex-snapshot
Fragment-based drug discovery using NMR spectroscopy
inferredcites →https://doi.org/10.1007/s13361-011-0116-xopenalex-snapshot
Protein Conformation and Supercharging with DMSO from Aqueous Solution
inferredcites →https://doi.org/10.1007/s13361-011-0311-9openalex-snapshot
Reliable Determinations of Protein–Ligand Interactions by Direct ESI-MS Measurements. Are We There Yet?
inferredcites →https://doi.org/10.1007/s13361-016-1545-3openalex-snapshot
Native Mass Spectrometry: What is in the Name?
inferredcites →https://doi.org/10.1007/s13361-018-1951-9openalex-snapshot
MetaUniDec: High-Throughput Deconvolution of Native Mass Spectra
inferredcites →https://doi.org/10.1016/j.bmc.2014.05.056openalex-snapshot
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2014.05.070openalex-snapshot
HDX reveals unique fragment ligands for the vitamin D receptor
inferredcites →https://doi.org/10.1016/j.bpj.2010.06.062openalex-snapshot
A Method for Removing Effects of Nonspecific Binding on the Distribution of Binding Stoichiometries: Application to Mass Spectroscopy Data
inferredcites →https://doi.org/10.1016/j.chembiol.2018.10.001openalex-snapshot
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures
inferredcites →https://doi.org/10.1016/j.ddtec.2010.12.001openalex-snapshot
The heat is on: thermodynamic analysis in fragment-based drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2010.08.013openalex-snapshot
Thermodynamics guided lead discovery and optimization
inferredcites →https://doi.org/10.1016/j.drudis.2019.03.009openalex-snapshot
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design
inferredcites →https://doi.org/10.1016/j.drudis.2019.12.006openalex-snapshot
Fragment-based drug discovery using cryo-EM
inferredcites →https://doi.org/10.1016/j.drudis.2023.103760openalex-snapshot
Affinity selection mass spectrometry speeding drug discovery
inferredcites →https://doi.org/10.1016/j.ejps.2015.05.001openalex-snapshot
Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90
inferredcites →https://doi.org/10.1016/j.jasms.2004.05.005openalex-snapshot
Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the titration method
inferredcites →https://doi.org/10.1016/j.jasms.2006.03.017openalex-snapshot
Direct screening of a dynamic combinatorial library using mass spectrometry
inferredcites →https://doi.org/10.1016/j.jasms.2006.05.005openalex-snapshot
A deconvolution method for the separation of specific versus nonspecific interactions in noncovalent protein-ligand complexes analyzed by ESI-FT-ICR mass spectrometry
inferredcites →https://doi.org/10.1016/j.jasms.2008.10.008openalex-snapshot
How to deal with weak interactions in noncovalent complexes analyzed by electrospray mass spectrometry: Cyclopeptidic inhibitors of the nuclear receptor coactivator 1-STAT6
inferredcites →https://doi.org/10.1016/j.jasms.2009.12.002openalex-snapshot
Nonspecific interactions between proteins and charged biomolecules in electrospray ionization mass spectrometry
inferredcites →https://doi.org/10.1016/j.jasms.2010.07.008openalex-snapshot
Quantifying labile protein—Ligand interactions using electrospray ionization mass spectrometry
inferredcites →https://doi.org/10.1016/j.pbiomolbio.2014.08.004openalex-snapshot
Advantages of crystallographic fragment screening: Functional and mechanistic insights from a powerful platform for efficient drug discovery
inferredcites →https://doi.org/10.1016/j.tibs.2023.01.008openalex-snapshot
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
inferredcites →https://doi.org/10.1016/j.trac.2023.117161openalex-snapshot
Advances in analytical technologies detecting and characterizing noncovalent interactions for fragment-based drug discovery
inferredcites →https://doi.org/10.1016/j.ymeth.2019.04.024openalex-snapshot
RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry
inferredcites →https://doi.org/10.1016/s1074-5521(96)90083-6openalex-snapshot
Mass spectrometry and viral analysis
inferredcites →https://doi.org/10.1016/s1387-3806(02)00585-7openalex-snapshot
Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry
inferredcites →https://doi.org/10.1021/ac061109dopenalex-snapshot
Method for Stabilizing Protein−Ligand Complexes in Nanoelectrospray Ionization Mass Spectrometry
inferredcites →https://doi.org/10.1021/ac201576eopenalex-snapshot
Quantifying Protein–Protein Interactions Within Noncovalent Complexes Using Electrospray Ionization Mass Spectrometry
inferredcites →https://doi.org/10.1021/ac303197popenalex-snapshot
Influence of Dimehylsulfoxide on Protein–Ligand Binding Affinities
inferredcites →https://doi.org/10.1021/ac400236zopenalex-snapshot
Nanoelectrospray Ionization Mass Spectrometric Study of Mycobacterium tuberculosis CYP121–Ligand Interactions
inferredcites →https://doi.org/10.1021/ac980563hopenalex-snapshot
Direct Determination of Solution Binding Constants for Noncovalent Complexes between Bacterial Cell Wall Peptide Analogues and Vancomycin Group Antibiotics by Electrospray Ionization Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.analchem.0c03784openalex-snapshot
Uniting Native Capillary Electrophoresis and Multistage Ultraviolet Photodissociation Mass Spectrometry for Online Separation and Characterization of Escherichia coli Ribosomal Proteins and Protein Complexes
inferredcites →https://doi.org/10.1021/acs.analchem.0c04342openalex-snapshot
Native Mass Spectrometry of Membrane Proteins
inferredcites →https://doi.org/10.1021/acs.analchem.0c04975openalex-snapshot
Separation and Characterization of Endogenous Nucleosomes by Native Capillary Zone Electrophoresis–Top-Down Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.analchem.2c04263openalex-snapshot
Matrix-Landing Mass Spectrometry for Electron Microscopy Imaging of Native Protein Complexes
inferredcites →https://doi.org/10.1021/acs.analchem.3c02010openalex-snapshot
UniDec Processing Pipeline for Rapid Analysis of Biotherapeutic Mass Spectrometry Data
inferredcites →https://doi.org/10.1021/acs.analchem.5b00140openalex-snapshot
Bayesian Deconvolution of Mass and Ion Mobility Spectra: From Binary Interactions to Polydisperse Ensembles
inferredcites →https://doi.org/10.1021/acs.analchem.5b02258openalex-snapshot
Deconvolution Method for Specific and Nonspecific Binding of Ligand to Multiprotein Complex by Native Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.analchem.8b02725openalex-snapshot
Native Proteomics in Discovery Mode Using Size-Exclusion Chromatography–Capillary Zone Electrophoresis–Tandem Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.chemrev.1c00212openalex-snapshot
High-Resolution Native Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.chemrev.1c00217openalex-snapshot
Characterizing Endogenous Protein Complexes with Biological Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.chemrev.1c00293openalex-snapshot
Protein–Small Molecule Interactions in Native Mass Spectrometry
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c01608openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2019
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c01895openalex-snapshot
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01803openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2020
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c01827openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2021
inferredcites →https://doi.org/10.1021/acs.jmedchem.3c00034openalex-snapshot
Fragment-Based Approaches to Identify RNA Binders
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01940openalex-snapshot
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00007openalex-snapshot
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b01123openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2015
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00606openalex-snapshot
Identification of a New Zinc Binding Chemotype by Fragment Screening
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b01298openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2016
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b01040openalex-snapshot
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b01472openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2017
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b00304openalex-snapshot
FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b00809openalex-snapshot
Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01581openalex-snapshot
Fragment-to-Lead Medicinal Chemistry Publications in 2018
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01670openalex-snapshot
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
inferredcites →https://doi.org/10.1021/acs.jproteome.2c00595openalex-snapshot
Onto Grid Purification and 3D Reconstruction of Protein Complexes Using Matrix-Landing Native Mass Spectrometry
inferredcites →https://doi.org/10.1021/acschembio.0c00899openalex-snapshot
Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A2A Receptor Targeting the Sodium Ion Pocket
inferredcites →https://doi.org/10.1021/acschembio.5b01034openalex-snapshot
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study
inferredcites →https://doi.org/10.1021/acsinfecdis.7b00197openalex-snapshot
Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
inferredcites →https://doi.org/10.1021/acsnano.2c04831openalex-snapshot
A Preparative Mass Spectrometer to Deposit Intact Large Native Protein Complexes
inferredcites →https://doi.org/10.1021/cb400582bopenalex-snapshot
Plasmodium Gametocyte Inhibition Identified from a Natural-Product-Based Fragment Library
inferredcites →https://doi.org/10.1021/cb400912xopenalex-snapshot
An Overview of Australia’s Compound Management Facility: The Queensland Compound Library
inferredcites →https://doi.org/10.1021/ja00016a069openalex-snapshot
Detection of noncovalent receptor-ligand complexes by mass spectrometry
inferredcites →https://doi.org/10.1021/ja00022a058openalex-snapshot
Observation of the heme-globin complex in native myoglobin by electrospray-ionization mass spectrometry
inferredcites →https://doi.org/10.1021/ja00063a079openalex-snapshot
Observation of a noncovalent ribonuclease S-protein/S-peptide complex by electrospray ionization mass spectrometry
inferredcites →https://doi.org/10.1021/jacs.6b07440openalex-snapshot
Disrupting the Constitutive, Homodimeric Protein–Protein Interface in CK2β Using a Biophysical Fragment-Based Approach
inferredcites →https://doi.org/10.1021/jacs.9b02822openalex-snapshot
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
inferredcites →https://doi.org/10.1021/jasms.1c00036openalex-snapshot
Denaturing and Native Mass Spectrometric Analytics for Biotherapeutic Drug Discovery Research: Historical, Current, and Future Personal Perspectives
inferredcites →https://doi.org/10.1021/jasms.3c00175openalex-snapshot
A Research Journey: Over a Decade of Denaturing and Native-MS Analyses of Hydrophobic and Membrane Proteins in Amgen Therapeutic Discovery
inferredcites →https://doi.org/10.1021/jasms.9b00119openalex-snapshot
Isotope Depletion Mass Spectrometry (ID-MS) for Accurate Mass Determination and Improved Top-Down Sequence Coverage of Intact Proteins
inferredcites →https://doi.org/10.1021/jm0507532openalex-snapshot
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
inferredcites →https://doi.org/10.1021/jm070091bopenalex-snapshot
Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery
inferredcites →https://doi.org/10.1021/jm301762vopenalex-snapshot
Discovery of 4-Amino- N -[(1 S )-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases
inferredcites →https://doi.org/10.1021/jp206867aopenalex-snapshot
Structural Stability from Solution to the Gas Phase: Native Solution Structure of Ubiquitin Survives Analysis in a Solvent-Free Ion Mobility–Mass Spectrometry Environment
inferredcites →https://doi.org/10.1038/nature09454openalex-snapshot
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
inferredcites →https://doi.org/10.1038/nature12796openalex-snapshot
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
inferredcites →https://doi.org/10.1038/nchem.217openalex-snapshot
The rise of fragment-based drug discovery
inferredcites →https://doi.org/10.1038/nchembio.2515openalex-snapshot
Top-down characterization of endogenous protein complexes with native proteomics
inferredcites →https://doi.org/10.1038/nrd.2016.109openalex-snapshot
Twenty years on: the impact of fragments on drug discovery
inferredcites →https://doi.org/10.1038/s41467-020-18709-wopenalex-snapshot
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1038/s41592-020-0821-0openalex-snapshot
Combining native and ‘omics’ mass spectrometry to identify endogenous ligands bound to membrane proteins
inferredcites →https://doi.org/10.1039/c0an00373eopenalex-snapshot
How useful is ion mobility mass spectrometry for structural biology? The relationship between protein crystal structures and their collision cross sections in the gas phase
inferredcites →https://doi.org/10.1039/c5md00518copenalex-snapshot
Covalent tethering of fragments for covalent probe discovery
inferredcites →https://doi.org/10.1039/c9md90044fopenalex-snapshot
A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA
inferredcites →https://doi.org/10.1039/d1cb00085copenalex-snapshot
19 F NMR viewed through two different lenses: ligand-observed and protein-observed 19 F NMR applications for fragment-based drug discovery
inferredcites →https://doi.org/10.1039/d2fd00065bopenalex-snapshot
Cryo-EM samples of gas-phase purified protein assemblies using native electrospray ion-beam deposition
inferredcites →https://doi.org/10.1039/d2md00197gopenalex-snapshot
PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery
inferredcites →https://doi.org/10.1039/d2md90037hopenalex-snapshot
Introduction to the themed collection on fragment-based drug discovery
inferredcites →https://doi.org/10.1039/d3sc01171bopenalex-snapshot
Fragment expansion with NUDELs – poised DNA-encoded libraries
inferredcites →https://doi.org/10.1042/bst20190694openalex-snapshot
Fragments: where are we now?
inferredcites →https://doi.org/10.1056/nejmoa1411366openalex-snapshot
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
inferredcites →https://doi.org/10.1071/ch13190openalex-snapshot
Fragment Screening by Native State Mass Spectrometry
inferredcites →https://doi.org/10.1073/pnas.0711741105openalex-snapshot
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
inferredcites →https://doi.org/10.1073/pnas.1219457110openalex-snapshot
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor
inferredcites →https://doi.org/10.1073/pnas.1807439115openalex-snapshot
N-glycan microheterogeneity regulates interactions of plasma proteins
inferredcites →https://doi.org/10.1093/annonc/mdg316openalex-snapshot
The Hsp90 chaperone complex as a novel target for cancer therapy
inferredcites →https://doi.org/10.1093/pnasnexus/pgac153openalex-snapshot
Mass-selective and ice-free electron cryomicroscopy protein sample preparation via native electrospray ion-beam deposition
inferredcites →https://doi.org/10.1101/2023.08.17.553673openalex-snapshot
Cryo-EM of soft-landed β -galactosidase: Gas-phase and native structures are remarkably similar
inferredcites →https://doi.org/10.1110/ps.0232503openalex-snapshot
Using nondenaturing mass spectrometry to detect fortuitous ligands in orphan nuclear receptors
inferredcites →https://doi.org/10.1126/sciadv.adl4628openalex-snapshot
Cryo-EM of soft-landed β-galactosidase: Gas-phase and native structures are remarkably similar
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.1126/science.aau0976openalex-snapshot
Protein assemblies ejected directly from native membranes yield complexes for mass spectrometry
inferredcites →https://doi.org/10.1146/annurev-biophys-092721-085421openalex-snapshot
Native Mass Spectrometry: Recent Progress and Remaining Challenges
inferredcites →https://doi.org/10.1146/annurev-physchem-040214-121732openalex-snapshot
Mass Spectrometry of Protein Complexes: From Origins to Applications
inferredcites →https://doi.org/10.1146/annurev.biophys.33.110502.140409openalex-snapshot
Tethering: Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1177/1087057110380455openalex-snapshot
Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12
inferredcites →https://doi.org/10.1177/1087057115622605openalex-snapshot
Bioaffinity Mass Spectrometry Screening
inferredcites →https://doi.org/10.1177/2472555218775921openalex-snapshot
Application of Native ESI-MS to Characterize Interactions between Compounds Derived from Fragment-Based Discovery Campaigns and Two Pharmaceutically Relevant Proteins
inferredcites →https://doi.org/10.1517/17460441.1.3.225openalex-snapshot
Fragment screening by biochemical assay
inferredcites →https://doi.org/10.2210/pdb6qa4/pdbopenalex-snapshot
ERK2 mini-fragment binding
inferredcites →https://doi.org/10.3389/fchem.2020.00093openalex-snapshot
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
inferredcites →https://doi.org/10.3389/fmolb.2022.834453openalex-snapshot
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
inferredcites →https://doi.org/10.3389/fmolb.2022.837901openalex-snapshot
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
inferredcites →https://doi.org/10.3390/molecules21070860openalex-snapshot
Applications of 19F-NMR in Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.3390/molecules24234309openalex-snapshot
Concepts and Core Principles of Fragment-Based Drug Design
inferredcites →https://doi.org/10.3390/molecules26103010openalex-snapshot
The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening
inferredcites →https://doi.org/10.4155/fmc.09.141openalex-snapshot
Native Ms: An ‘Esi’ Way to Support Structure- and Fragment-Based Drug Discovery

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/slct.202507418openalex-snapshot
Drug Discovery and Computational Chemistry: A State‐of‐the‐Art Review
inferred← citeshttps://doi.org/10.1007/s10822-026-00950-yopenalex-snapshot
In silico designing of small molecules for targeting RNA: current landscape and future directions
inferred← citeshttps://doi.org/10.1016/j.aca.2024.343551openalex-snapshot
Emerging opportunities for intact and native protein analysis using chemical proteomics
inferred← citeshttps://doi.org/10.1016/j.crphar.2025.100233openalex-snapshot
Fragment-based drug discovery: A graphical review
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117695openalex-snapshot
Virtual screening and fragment growth strategy for developing near-infrared fluorescent probes to detect Aβ in Alzheimer's disease model
inferred← citeshttps://doi.org/10.1016/j.slast.2025.100245openalex-snapshot
High-throughput hit identification with acoustic ejection mass spectrometry
inferred← citeshttps://doi.org/10.1021/acs.biochem.5c00006openalex-snapshot
The Druggable Transcriptome Project: From Chemical Probes to Precision Medicines
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01512openalex-snapshot
Investigating Active Site Binding of Ligands to High and Low Activity Carbonic Anhydrase Enzymes Using Native Mass Spectrometry
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c03115openalex-snapshot
Target Engagement Assays in Early Drug Discovery
inferred← citeshttps://doi.org/10.1038/s41467-026-68941-zopenalex-snapshot
Developments and challenges in hit progression within fragment-based drug discovery
inferred← citeshttps://doi.org/10.1038/s44386-026-00048-3openalex-snapshot
Assessing the ligand native-like pose using a quantum mechanical-derived hydropathic score for protein-ligand complementarity
inferred← citeshttps://doi.org/10.1039/d5md00617aopenalex-snapshot
Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development
inferred← citeshttps://doi.org/10.1071/ch25081openalex-snapshot
Electrophilic fragment screening using native mass spectrometry to identify covalent probes for surface cysteines
inferred← citeshttps://doi.org/10.1080/17568919.2026.2726188openalex-snapshot
Rational drug design, synthetic and artificial intelligence approaches for bioactive heterocycles: advances and perspectives
inferred← citeshttps://doi.org/10.1080/19420862.2026.2699078openalex-snapshot
Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
inferred← citeshttps://doi.org/10.1101/2025.10.20.683430openalex-snapshot
Assessing the ligand native-like pose using a quantum mechanical-derived hydropathic score for protein-ligand complementarity
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.